Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease

Abstract Systemic sclerosis (SSc) is a severe multi-organ disease with interstitial lung disease (ILD) being the major cause of death. While targeted therapies are emerging, biomarkers for sub-stratifying patients based on individual profiles are lacking. Herein, we investigated how levels of serum...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: C. Meier, K. Freiburghaus, C. Bovet, J. Schniering, Y. Allanore, O. Distler, C. Nakas, B. Maurer
Format: article
Langue:EN
Publié: Nature Portfolio 2020
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/4f13a07c3c2549ea99406944b37d68ba
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!